GlassScriptPhysician profile
Alicia A Shields
NPI 1629416235
$1,051.27
in general payments reported to CMS, 2019-2025
11 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.41 · 2021: $13.52 · 2023: $459 · 2024: $273 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930 · Education: $90.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $930.39 |
| Education | $90.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $400.00 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $148.79 | 2023-2025 | Slynd |
| Abbvie INC. | $145.89 | 2019-2023 | Liletta, Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $107.29 | 2023-2025 | |
| Sage Therapeutics, LLC | $73.99 | 2023-2025 | Zurzuvae |
| Organon LLC | $43.13 | 2023-2024 | Nexplanon |
| Evofem Biosciences, INC. | $38.23 | 2024-2025 | Solosec, Phexx, Phexxi |
| Aspira Women'S Health INC | $31.26 | 2023 | Ova1 |
| Pfizer INC. | $23.59 | 2025 | |
| Coopersurgical, INC. | $21.42 | 2023 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $17.68 | 2025 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alicia Shields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.